KraneShares MSCI All China Health Care Index ETF (KURE)

Assets	$79.28M
Expense Ratio	0.65%
PE Ratio	26.25
Shares Out	4.70M
Dividend (ttm)	$0.71
Dividend Yield	4.38%
Ex-Dividend Date	Dec 22, 2025
Payout Frequency	Annual
Payout Ratio	111.43%

Volume	6,779
Open	16.54
Previous Close	16.83
Day's Range	16.32 - 16.75
52-Week Low	15.20
52-Week High	21.88
Beta	0.19
Holdings	50
Inception Date	Feb 1, 2018

About KURE

Fund Home Page

The KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. KURE was launched on Feb 1, 2018 and is issued by KraneShares.

• Asset Class: Equity
• Category: Greater China Region
• Region: Asia-Pacific
• Stock Exchange: NYSEARCA
• Ticker Symbol: KURE
• ETF Provider: KraneShares
• Index Tracked: MSCI China All Shares Health Care 10/40 Index

Top 10 Holdings

54.97% of assets

Name	Symbol	Weight
Innovent Biologics, Inc.	1801	9.01%
BeOne Medicines AG	6160	8.84%
WuXi Biologics (Cayman) Inc.	2269	6.80%
WuXi AppTec Co., Ltd.	603259	5.95%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd	600276	4.60%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.	300760	4.30%
Akeso, Inc.	9926	4.21%
Sino Biopharmaceutical Limited	1177	4.10%
Hansoh Pharmaceutical Group Company Limited	3692	3.77%
WuXi AppTec Co., Ltd.	2359	3.39%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 22, 2025	$0.71469	Dec 23, 2025
Dec 17, 2024	$0.18361	Dec 18, 2024
Dec 18, 2023	$0.11284	Dec 20, 2023
Dec 28, 2022	$0.0104	Dec 30, 2022
Dec 29, 2021	$4.05354	Dec 31, 2021
Dec 29, 2020	$0.00011	Dec 31, 2020

Performance

KURE had a total return of 10.61% in the past year, including dividends. Since the fund's inception, the average annual return has been -2.55%.